Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elvucitabine vs Lamivudine in treatment-naive HIV-1 infection
NCT00350272Phase 2Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- May 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of elvucitabine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Alexion Pharmaceuticals. Started May 2006; status: completed.
02
Drugs
elvucitabine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00350272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00350272.